All Stories

  1. Practices, Resources and Challenges in Parkinson's Disease Management in Asia: Movement Disorders in Asia Study Group Report
  2. Progressive Supranuclear Palsy—A Global Review
  3. Association of Bassoon (BSN) Gene Mutations with Gait and Motor Impairments in Parkinson's Disease
  4. Preface to the Sixth MDS Video Challenge Case Supplement for Movement Disorders Clinical Practice
  5. Can simple home-based exercises reduce the fear of falling in Parkinsonian disorders?
  6. Bassoon, Presynaptic Scaffolding Protein: Narrative Review in Health and Disease
  7. Bassoon, Presynaptic scaffolding protein: Narrative Review in Health and Disease
  8. Levodopa Equivalent Daily Dosage: Geographical Variations and Real‐Life Modules in Parkinson's Disease
  9. Exercise Habits in People with Parkinson's: A Multinational Survey
  10. Movement Disorders in Patients with Subacute Sclerosing Panencephalitis: A Systematic Review
  11. The Genetic Drivers of Juvenile, Young, and Early‐Onset Parkinson's Disease in India
  12. Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience
  13. Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson's Disease: A Systematic Review
  14. The genetic drivers of juvenile, young, and early-onset Parkinson’s Disease in India
  15. Genetic Movement Disorders Commonly Seen in Asians
  16. Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals
  17. iSTIMULI: Prescriptive Stimulus Design for Eye Movement Analysis of Patients with Parkinson’s Disease
  18. Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions
  19. Genome‐Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from India
  20. Oculogyric Crisis Phenotype of Levodopa‐Induced Ocular Dyskinesia
  21. COVID-19: The cynosure of rise of Parkinson's disease
  22. The Spectrum of Movement Disorders in Tertiary Care Centers in India
  23. Wilson's Disease Update
  24. Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life
  25. Chorea-acanthocytosis
  26. PRRT2 Gene Mutations in Indian Paroxysmal Kinesigenic Dyskinesia Patients
  27. Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation
  28. Hypoparathyroidism Masquerading as Corticobasal Syndrome
  29. Clinical Study of 668 Indian Subjects with Juvenile, Young, and Early Onset Parkinson’s Disease
  30. GP2: The Global Parkinson's Genetics Program
  31. Impact of home confinement during COVID-19 pandemic on sleep parameters in Parkinson's disease
  32. Huntington’s disease
  33. Reply to: Fatal Familial Insomnia: A Rare Disease with Unique Clinico‐Neurophysiological Features
  34. Impact of home confinement during COVID-19 pandemic on Parkinson's disease
  35. Does Apomorphine Have an Effect on Body Weight? An Observational Study
  36. A Case of Autosomal Dominant Ataxia with Vocal Cord Palsy Attributed to a Mutation in the PRNP Gene
  37. Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease Research
  38. Looking beyond the fog—apomorphine demystified
  39. Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population
  40. Apomorphine: The initial indian experience in relation to response tests and pumps
  41. The chronicles of modern movement disorders in India
  42. Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India
  43. Surgical treatment of dystonia
  44. First Case report of PARK 9 from India
  45. Minimal change multiple system atrophy: An aggressive variant?
  46. Over-the-counter self-medication leading to intracranial hypertension in a young lady
  47. Amantadine improves gait in PD patients with STN stimulation
  48. Reply to letter: multiple system atrophy-parkinsonism with slow progression and prolonged survival: A diagnostic catch
  49. A randomized trial of varenicline (chantix) for the treatment of spinocerebellar ataxia type 3
  50. Psychogenic facial movement disorders: Clinical features and associated conditions
  51. Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
  52. Multiple system atrophy-parkinsonism with slow progression and prolonged survival: A diagnostic catch
  53. Extreme task specificity: Is it dystonia or another form of motor programming abnormality?
  54. Brain Activation Studies in Parkinson’s Disease
  55. l-Dopa-Induced Dyskinesia—Clinical Presentation, Genetics, and Treatment
  56. Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates
  57. Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100 cases
  58. Wilson’s disease: 31P and 1H MR spectroscopy and clinical correlation
  59. Wilson′s disease : An Indian perspective
  60. Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge!
  61. Psychiatric Manifestations in Wilson's Disease: A Cross-Sectional Analysis
  62. Quality of life in Wilson′s disease
  63. Central Pontine Signal Changes in Wilson's Disease: Distinct MRI Morphology and Sequential Changes with De-Coppering Therapy
  64. Sequential MRI changes in Wilson's disease with de-coppering therapy: a study of 50 patients
  65. Subacute Sclerosing Panencephalitis (SSPE): An Insight Into the Diagnostic Errors From a Tertiary Care University Hospital
  66. Long term survival in subacute sclerosing panencephalitis: An enigma
  67. Wilson’s disease: cranial MRI observations and clinical correlation
  68. Adult onset subacute sclerosing panencephalitis: clinical profile of 39 patients from a tertiary care centre
  69. Prognostic factors in patients presenting with severe neurological forms of Wilson's disease
  70. Is low serum tocopherol in Wilson's disease a significant symptom?
  71. Wilson's disease: diagnostic errors and clinical implications
  72. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson's disease